IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v12y2021i1d10.1038_s41467-021-23212-x.html
   My bibliography  Save this article

CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph

Author

Listed:
  • Luca Hensen

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Patricia T. Illing

    (Biomedicine Discovery Institute, Monash University)

  • E. Bridie Clemens

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Thi H. O. Nguyen

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Marios Koutsakos

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Carolien E. Sandt

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity
    University of Amsterdam)

  • Nicole A. Mifsud

    (Biomedicine Discovery Institute, Monash University)

  • Andrea T. Nguyen

    (Biomedicine Discovery Institute, Monash University)

  • Christopher Szeto

    (Biomedicine Discovery Institute, Monash University)

  • Brendon Y. Chua

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Hanim Halim

    (Biomedicine Discovery Institute, Monash University)

  • Simone Rizzetto

    (UNSW Sydney)

  • Fabio Luciani

    (UNSW Sydney)

  • Liyen Loh

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Emma J. Grant

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity
    Biomedicine Discovery Institute, Monash University)

  • Phillipa M. Saunders

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Andrew G. Brooks

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Steve Rockman

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity
    Seqirus)

  • Tom C. Kotsimbos

    (Immunology and Respiratory Medicine, The Alfred Hospital
    Monash University, Central Clinical School, The Alfred Hospital)

  • Allen C. Cheng

    (Monash University
    Infection Prevention and Healthcare Epidemiology Unit, Alfred Health)

  • Michael Richards

    (Victorian Infectious Diseases Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Glen P. Westall

    (Lung Transplant Unit, Alfred Hospital)

  • Linda M. Wakim

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Thomas Loudovaris

    (Immunology and Diabetes Unit, St Vincent’s Institute of Medical Research)

  • Stuart I. Mannering

    (Immunology and Diabetes Unit, St Vincent’s Institute of Medical Research)

  • Michael Elliott

    (University of Sydney
    Royal Prince Alfred Hospital)

  • Stuart G. Tangye

    (Garvan Institute of Medical Research
    University of New South Wales)

  • David C. Jackson

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

  • Katie L. Flanagan

    (Launceston General Hospital
    University of Tasmania
    Monash University
    RMIT University)

  • Jamie Rossjohn

    (Biomedicine Discovery Institute, Monash University
    Cardiff University School of Medicine
    Monash University)

  • Stephanie Gras

    (Biomedicine Discovery Institute, Monash University
    Monash University
    La Trobe University)

  • Jane Davies

    (Menzies School of Health Research)

  • Adrian Miller

    (CQUniversity)

  • Steven Y. C. Tong

    (Victorian Infectious Diseases Service, The Royal Melbourne Hospital, and Doherty Department University of Melbourne, at the Peter Doherty Institute for Infection and Immunity
    Menzies School of Health Research)

  • Anthony W. Purcell

    (Biomedicine Discovery Institute, Monash University)

  • Katherine Kedzierska

    (University of Melbourne, at the Peter Doherty Institute for Infection and Immunity)

Abstract

Indigenous people worldwide are at high risk of developing severe influenza disease. HLA-A*24:02 allele, highly prevalent in Indigenous populations, is associated with influenza-induced mortality, although the basis for this association is unclear. Here, we define CD8+ T-cell immune landscapes against influenza A (IAV) and B (IBV) viruses in HLA-A*24:02-expressing Indigenous and non-Indigenous individuals, human tissues, influenza-infected patients and HLA-A*24:02-transgenic mice. We identify immunodominant protective CD8+ T-cell epitopes, one towards IAV and six towards IBV, with A24/PB2550–558-specific CD8+ T cells being cross-reactive between IAV and IBV. Memory CD8+ T cells towards these specificities are present in blood (CD27+CD45RA− phenotype) and tissues (CD103+CD69+ phenotype) of healthy individuals, and effector CD27−CD45RA−PD-1+CD38+CD8+ T cells in IAV/IBV patients. Our data show influenza-specific CD8+ T-cell responses in Indigenous Australians, and advocate for T-cell-mediated vaccines that target and boost the breadth of IAV/IBV-specific CD8+ T cells to protect high-risk HLA-A*24:02-expressing Indigenous and non-Indigenous populations from severe influenza disease.

Suggested Citation

  • Luca Hensen & Patricia T. Illing & E. Bridie Clemens & Thi H. O. Nguyen & Marios Koutsakos & Carolien E. Sandt & Nicole A. Mifsud & Andrea T. Nguyen & Christopher Szeto & Brendon Y. Chua & Hanim Halim, 2021. "CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph," Nature Communications, Nature, vol. 12(1), pages 1-20, December.
  • Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23212-x
    DOI: 10.1038/s41467-021-23212-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-021-23212-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-021-23212-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-23212-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.